Bill Atkins is the leader of Pillsbury Shaw Pittman LLP's Intellectual Property Litigation team. Mr. Atkins is a trial and appellate lawyer with over 20 years of experience. He is a registered patent attorney who has won jury verdicts and decisions on both sides of the courtroom. Some of his most recent courtroom victories include (1) getting two university co-inventors added to NIH-owned cancer drug patents which have had annual sales of approximately $2B, (2) getting a jury verdict of infringement for a consumer product against their major competitor, and (3) getting a jury verdict for a client in defense of $200M+ patent infringement and related allegations.
Mr. Atkins has been lead counsel in over 100 intellectual property litigations and has extensive experience in patent, trademark, trade secret, Lanham Act, unfair competition and copyright matters. Over the course of his career, Mr. Atkins has been in trial and appellate courts, the International Trade Commission, arbitrations, mediations, and before the U.S. Patent and Trademark Office many times.
He is a Past President of the Foundation of the Bar Association of D.C. (2007-09) and has been President of the Bar Association of D.C. (2005-06), a member of the ABA's House of Delegates, and chaired numerous bar committees. He is a prolific writer having recently published a primer on ITC procedure in English, Japanese, and Chinese. The primer was judged as one of the ten best law review articles related to patent law when it was published by the editor of West's Intellectual Property Law Review (2011). He has also been a member of Pillsbury’s Managing Board, co-leader of the firm's IP section, Managing Partner of the Northern Virginia office, and a member of the firm's Compensation Committee.
He received his B.S. from University of Maryland, his LL.M. from The George Washington University Law School, and his J.D./M.B.A. from the University of Baltimore School of Law.
Mr. Atkins is an Editor-in-Chief of the ABA/Bloomberg BNA treatise Patent Litigation Strategies Handbook, Third Edition (2014 Cumulative Supplement).
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)